1. Home
  2. NTRB

as 12-18-2024 11:40am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Founded: 2016 Country:
United States
United States
Employees: N/A City: ORLANDO
Market Cap: 77.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 27.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.69 EPS Growth: N/A
52 Week Low/High: $2.22 - $9.60 Next Earning Date: 12-04-2024
Revenue: $2,021,771 Revenue Growth: -3.18%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

NTRB Daily Stock ML Predictions

Share on Social Networks: